MSH|^~\&|LAB|Dynacare|||20230906014419-0400||ORU^R01|20274302|D|2.3|||||||enCA
PID|1||2222225941^^^^JHN^~^^^^XXOEI^||Lastname^Firstname^Middlename||19790403|F|||9 Toronto Street^Unit 29^Toronto^ON^ABCDEFG^||^|||||
ORC||^Dynacare|5010019816||CM||||20230825102610-0400||||||||^TEST^DYNA
OBR|1|^Dynacare|5010019816|544D^ANTINUCLEAR AB. (ANA)^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||AUTO|400090|20230831143406-0400|||F|^^||
OBX|1|TX|544D^ANTINUCLEAR AB. (ANA)^DYNA|400090|NEGATIVE||NEGATIVE|N|||F|||20230831143406-0400
NTE|1|RS||RS^^DYNA^IM17
NTE|2|RS|A negative test is strong evidence against a diagnosis of|RS^^DYNA^IM17
NTE|3|RS|rheumatic disease but is not conclusive. Results should be|RS^^DYNA^IM17
NTE|4|RS|interpreted in conjunction with other serological tests and|RS^^DYNA^IM17
NTE|5|RS|clinical findings.|RS^^DYNA^IM17
NTE|6|RS||RS^^DYNA^IM17
NTE|7|RS||RS^^DYNA^IM17
NTE|8|RF|NEGATIVE|RF^^^
OBR|2|^Dynacare|5010019816|111G^GLUCOSE SERUM FASTING^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||CHEM|112007|20230831142820-0400|||F|^^||
OBX|1|NM|111G^GLUCOSE SERUM FASTING^DYNA|112007|4.8|mmol/L|3.6 - 6|N|||F|||20230831142820-0400
NTE|1|RF|mmol/L|RF^^^
NTE|2|RF|3.6 - 6.0 NORMAL FASTING GLUCOSE|RF^^^
NTE|3|RF|6.1 - 6.9 IMPAIRED FASTING GLUCOSE|RF^^^
NTE|4|RF|>6.9 PROVISIONAL DIAGNOSIS OF DIABETES MELLITUS|RF^^^
OBR|3|^Dynacare|5010019816|HF^HOURS FASTING^DYNA|||20230825102610-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||CHEM|114398|20230825104048-0400|||F|^^||
OBX|1|NM|HF^HOURS FASTING^DYNA|114398|14.|hrs||I|||F|||20230825104048-0400
NTE|1|RF|hours|RF^^^
OBR|4|^Dynacare|5010019816|055M^CHOLESTEROL^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||CHEM|114403|20230831142830-0400|||F|^^||
OBX|1|NM|055M^CHOLESTEROL^DYNA|114403|4.65|mmol/L|< 5.2|N|||F|||20230831142830-0400
NTE|1|RF|< 5.20 mmol/L|RF^^^
NTE|2|RF|Total cholesterol and HDL-C used|RF^^^
NTE|3|RF|for risk assessment and to calculate non-HDL-C.|RF^^^
NTE|4|RF|Effective April 17, 2023,|RF^^^
NTE|5|RF|please note a change in decision limit.|RF^^^
OBR|5|^Dynacare|5010019816|243M^TRIGLYCERIDES^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||CHEM|114425|20230831142836-0400|||F|^^||
OBX|1|NM|243M^TRIGLYCERIDES^DYNA|114425|1.22|mmol/L|< 1.7|N|||F|||20230831142836-0400
NTE|1|RF|< 1.70 mmol/L|RF^^^
NTE|2|RF|If nonfasting,|RF^^^
NTE|3|RF|triglycerides <2.00 mmol/L desired.|RF^^^
NTE|4|RF|Effective April 17, 2023,|RF^^^
NTE|5|RF|please note a change in decision limit.|RF^^^
OBR|6|^Dynacare|5010019816|117M^HDL CHOLESTEROL^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||CHEM|114428|20230831142842-0400|||F|^^||
OBX|1|NM|117M^HDL CHOLESTEROL^DYNA|114428|1.47|mmol/L|>= 1.3|N|||F|||20230831142842-0400
NTE|1|RF|mmol/L|RF^^^
NTE|2|RF|F: >=1.30 mmol/L|RF^^^
NTE|3|RF|HDL-C <1.30 mmol/L indicates risk for metabolic syndrome.|RF^^^
NTE|4|RF|Effective April 17, 2023,|RF^^^
NTE|5|RF|please note a change in decision limit.|RF^^^
OBR|7|^Dynacare|5010019816|LDLM^LDL CHOLESTEROL CALC.^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||CHEM|114431|20230831142842-0400|||F|^^||
OBX|1|NM|LDLM^LDL CHOLESTEROL CALC.^DYNA|114431|2.68|mmol/L|< 3.5|N|||F|||20230831142842-0400
NTE|1|RF|< 3.50 mmol/L|RF^^^
NTE|2|RF|LDL-C was calculated using the|RF^^^
NTE|3|RF|NIH equation.|RF^^^
NTE|4|RF|For additional LDL-C and non-HDL-C thresholds|RF^^^
NTE|5|RF|based on risk stratification,|RF^^^
NTE|6|RF|refer to 2021 CCS Guidelines.|RF^^^
NTE|7|RF|Effective April 17, 2023,|RF^^^
NTE|8|RF|please note a change in decision limit.|RF^^^
OBR|8|^Dynacare|5010019816|NHDL^NON-HDL-CHOLESTEROL(CALC^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||CHEM|114435|20230831142842-0400|||F|^^||
OBX|1|NM|NHDL^NON-HDL-CHOLESTEROL(CALC^DYNA|114435|3.18|mmol/L|< 4.2|N|||F|||20230831142842-0400
NTE|1|RF|< 4.20 mmol/L|RF^^^
NTE|2|RF|Effective April 17, 2023,|RF^^^
NTE|3|RF|please note a change in decision limit.|RF^^^
OBR|9|^Dynacare|5010019816|R/RM^TC/HDL-C RATIO^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||CHEM|114436|20230831142842-0400|||F|^^||
OBX|1|NM|R/RM^TC/HDL-C RATIO^DYNA|114436|3.2|||I|||F|||20230831142842-0400
OBR|10|^Dynacare|5010019816|093B^HEMOGLOBIN A1c^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||CHEM|115552|20230831142850-0400|||F|^^||
OBX|1|NM|093B^HEMOGLOBIN A1c^DYNA|115552|5.1|%|< 6|N|||F|||20230831142850-0400
NTE|1|RF|%|RF^^^
NTE|2|RF|NON-DIABETIC:            < 6.0  %|RF^^^
NTE|3|RF|PREDIABETES:         6.0 - 6.4  %|RF^^^
NTE|4|RF|DIABETIC:                > 6.4  %|RF^^^
NTE|5|RF|OPTIMAL CONTROL:         < 7.0  %|RF^^^
NTE|6|RF|SUB-OPTIMAL CONTROL: 7.0 - 8.4  %|RF^^^
NTE|7|RF|INADEQUATE CONTROL:      > 8.4  %|RF^^^
OBR|11|^Dynacare|5010019816|418^HEMOGLOBIN^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300004|20230831142854-0400|||F|^^||
OBX|1|NM|418^HEMOGLOBIN^DYNA|300004|138.|g/L|110 - 147|N|||F|||20230831142854-0400
NTE|1|RF|110 - 147  g/L|RF^^^
OBR|12|^Dynacare|5010019816|417^HEMATOCRIT^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300005|20230831142857-0400|||F|^^||
OBX|1|NM|417^HEMATOCRIT^DYNA|300005|0.41|L/L|0.33 - 0.44|N|||F|||20230831142857-0400
NTE|1|RF|0.33 - 0.44 l/l|RF^^^
OBR|13|^Dynacare|5010019816|397^RBC^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300010|20230831142906-0400|||F|^^||
OBX|1|NM|397^RBC^DYNA|300010|4.4|x 10*12/L|3.8 - 5.2|N|||F|||20230831142906-0400
NTE|1|RF|3.8 - 5.2  x 10E12/L|RF^^^
OBR|14|^Dynacare|5010019816|397V^RBC INDICES: MCV^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300011|20230831142911-0400|||F|^^||
OBX|1|NM|397V^RBC INDICES: MCV^DYNA|300011|93.|fL|76 - 98|N|||F|||20230831142911-0400
NTE|1|RF|76 - 98   fl|RF^^^
OBR|15|^Dynacare|5010019816|397H^.             MCH^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300012|20230831142915-0400|||F|^^||
OBX|1|NM|397H^.             MCH^DYNA|300012|31.|pg|24 - 33|N|||F|||20230831142915-0400
NTE|1|RF|24 - 33   pg|RF^^^
OBR|16|^Dynacare|5010019816|417C^.             MCHC^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300013|20230831142921-0400|||F|^^||
OBX|1|NM|417C^.             MCHC^DYNA|300013|329.|g/L|313 - 344|N|||F|||20230831142921-0400
NTE|1|RF|313 - 344  g/L|RF^^^
OBR|17|^Dynacare|5010019816|300014^RDW^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300014|20230831142925-0400|||F|^^||
OBX|1|NM|300014^RDW^DYNA|300014|14.8|%|12.5 - 17.3|N|||F|||20230831142925-0400
NTE|1|RF|12.5 - 17.3|RF^^^
OBR|18|^Dynacare|5010019816|399^WBC^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300015|20230831142932-0400|||F|^^||
OBX|1|NM|399^WBC^DYNA|300015|6.6|x 10*9/L|3.2 - 9.4|N|||F|||20230831142932-0400
NTE|1|RF|3.2 - 9.4 x 10E9/L|RF^^^
OBR|19|^Dynacare|5010019816|451^E.S.R.^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300020|20230831142939-0400|||F|^^||
OBX|1|NM|451^E.S.R.^DYNA|300020|15.|mm/hr|0 - 20|N|||F|||20230831142939-0400
NTE|1|RF|F:      0 - 20   mm/hr|RF^^^
OBR|20|^Dynacare|5010019816|396^PLATELETS^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300025|20230831142943-0400|||F|^^||
OBX|1|NM|396^PLATELETS^DYNA|300025|208.|x 10*9/L|155 - 372|N|||F|||20230831142943-0400
NTE|1|RF|155 - 372  x 10E9/L|RF^^^
OBR|21|^Dynacare|5010019816|300027^MPV^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300027|20230831142947-0400|||F|^^||
OBX|1|NM|300027^MPV^DYNA|300027|10.1|fL|4 - 14|N|||F|||20230831142947-0400
NTE|1|RF|4.0 - 14.0 fl|RF^^^
OBR|22|^Dynacare|5010019816|372^DIFFERENTIAL WBC'S :^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300040||||F|^^||
OBX|1|NM|NEUT^NEUTROPHILS^DYNA|300040.015|4.4|x 10*9/L|1.4 - 6.3|N|||F|||20230831143023-0400
NTE|1|RF|1.4 -6.3 x10E9/L|RF^^^
OBX|2|NM|LYMPH^LYMPHOCYTES^DYNA|300040.016|1.8|x 10*9/L|1 - 2.9|N|||F|||20230831143023-0400
NTE|1|RF|1.0 -2.9 x10E9/L|RF^^^
OBX|3|NM|MONO^MONOCYTES^DYNA|300040.017|0.3|x 10*9/L|0.2 - 0.8|N|||F|||20230831143023-0400
NTE|1|RF|0.2 -0.8 x10E9/L|RF^^^
OBX|4|NM|EOS^EOSINOPHILS^DYNA|300040.018|0.1|x 10*9/L|0 - 0.5|N|||F|||20230831143023-0400
NTE|1|RF|0.0 -0.5 x10E9/L|RF^^^
OBX|5|NM|BASO^BASOPHILS^DYNA|300040.019|0.00|x 10*9/L|0 - 0.09|N|||F|||20230831143023-0400
NTE|1|RF|0.00-0.09x10E9/L|RF^^^
OBR|23|^Dynacare|5010019816|372A^SMEAR:^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|300045||||F|^^||
OBX|1|TX|PLTMOR^PLATELETS^DYNA|300045.001|PLATELETS APPEAR ADEQUATE|||N|||F|||20230831143053-0400
OBX|2|TX|RBCMOR^RBC'S^DYNA|300045.004|RED CELLS APPEAR NORMAL|||N|||F|||20230831143053-0400
OBR|24|^Dynacare|5010019816|VWP^VON WILLEBRAND PANEL^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||HEMA|399800|20230831143318-0400|||F|^^||
OBX|1|TX|VWP^VON WILLEBRAND PANEL^DYNA|399800|See Notes|||I|||F|||20230831143318-0400
NTE|1|RS||RS^^DYNA^DCTC
NTE|2|RS|REVIEWED BY DR.DOUGLAS TKACHUK  M.D., F.R.C.P.(C)|RS^^DYNA^DCTC
NTE|3|RS||RS^^DYNA^DCTC
OBX|2|TX|VWP^VON WILLEBRAND PANEL^DYNA|399800|\.br\ Coagulation Factor VIII Activity is 1.43 U/mL .                                  \.br\ Factor VIII Activity Normal Range 0.60 - 1.71 U/mL                               \.br\                                                                                  \.br\ von Willebrand Factor Antigen is 0.88 U/mL .                                     \.br\ von Willebrand Factor Antigen  Normal Range 0.56 - 1.72 U/mL                     \.br\                                                                                  \.br\ von Willebrand Factor Activity is 0.92 U/mL .                                    \.br\ von Willebrand Factor Activity Normal Range  0.50 - 1.87 U/m                     \.br\                                                                                  \.br\ No evidence of von Willebrand's disease.|||I|||F|||20230831143318-0400
OBR|25|^Dynacare|5010019816|253^URINALYSIS CHEMICAL^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||URIN|500000||||F|^^||
OBX|1|TX|GLUCU^GLUCOSE^DYNA|500000.021|NEG|mmol/L|NEGATIVE|N|||F|||20230831143526-0400
NTE|1|RF|NEGATIVE (mmol/L)|RF^^^
OBX|2|TX|BILIU^BILIRUBIN^DYNA|500000.022|NEG||NEGATIVE|N|||F|||20230831143526-0400
NTE|1|RF|NEGATIVE|RF^^^
OBX|3|TX|KET^KETONES^DYNA|500000.023|NEG|mmol/L|NEGATIVE|N|||F|||20230831143526-0400
NTE|1|RF|NEGATIVE (mmol/L)|RF^^^
OBX|4|NM|S/G^SPECIFIC GRAVITY^DYNA|500000.024|1.020||1.005 - 1.03|N|||F|||20230831143526-0400
NTE|1|RF|1.005 - 1.030|RF^^^
OBX|5|TX|BLDU^BLOOD^DYNA|500000.025|NEG||NEGATIVE|N|||F|||20230831143526-0400
NTE|1|RF|NEGATIVE|RF^^^
OBX|6|NM|UPH^pH^DYNA|500000.026|6.5||5 - 8|N|||F|||20230831143526-0400
NTE|1|RF|5.0 - 8.0|RF^^^
OBX|7|TX|PROTU^PROTEIN^DYNA|500000.027|NEG|g/L|NEGATIVE|N|||F|||20230831143526-0400
NTE|1|RF|NEGATIVE (g/L)|RF^^^
OBX|8|NM|UBG^UROBILINOGEN^DYNA|500000.028|3.2|umol/L|3.2 - 16|N|||F|||20230831143526-0400
NTE|1|RF|3.2 - 16  umol/L|RF^^^
OBX|9|TX|NIT^NITRITE^DYNA|500000.029|NEG||NEGATIVE|N|||F|||20230831143526-0400
NTE|1|RF|NEGATIVE|RF^^^
OBX|10|TX|LEUK^LEUKOCYTES^DYNA|500000.030|NEG||NEGATIVE|N|||F|||20230831143526-0400
NTE|1|RF|NEGATIVE|RF^^^
OBX|11|TX|UCOLOR^COLOUR^DYNA|500000.031|YELLOW||YELLOW|N|||F|||20230831143526-0400
NTE|1|RF|YELLOW|RF^^^
OBX|12|TX|APPEAU^APPEARANCE^DYNA|500000.032|CLEAR||CLEAR|N|||F|||20230831143526-0400
NTE|1|RF|CLEAR|RF^^^
OBR|26|^Dynacare|5010019816|253A^URINALYSIS - MICRO^DYNA|||20230825102600-0400|||||||20230825102610-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA||||URIN|500005|20230831143704-0400|||F|^^||
OBX|1|TX|253A^URINALYSIS - MICRO^DYNA|500005|See Notes|||N|||F|||20230831143704-0400
NTE|1|RS||RS^^DYNA^OBSR
NTE|2|RS|Urine Microscopy examination looks for the presence of|RS^^DYNA^OBSR
NTE|3|RS|all cells, casts, crystals, bacteria and other elements.|RS^^DYNA^OBSR
NTE|4|RS|Only observed cells/elements in the urine are included|RS^^DYNA^OBSR
NTE|5|RS|on the report.|RS^^DYNA^OBSR
NTE|6|RS||RS^^DYNA^OBSR
OBX|2|TX|URBC^R.B.C.^DYNA|500005.001|0-2|/hpf|0 - 2|N|||F|||20230831143704-0400
NTE|1|RF|0 - 2   /HPF|RF^^^
OBX|3|TX|UEPIT^SQUAMOUS EPITHELIAL^DYNA|500005.002|0-5|/hpf|0 - 5|N|||F|||20230831143704-0400
NTE|1|RF|0 - 5   /HPF|RF^^^
OBX|4|TX|UWBC^W.B.C.^DYNA|500005.003|0-2|/hpf|0 - 2|N|||F|||20230831143704-0400
NTE|1|RF|0 - 2   /HPF|RF^^^
OBX|5|TX|UBAC^BACTERIA^DYNA|500005.004|NEG|/hpf|NEGATIVE|N|||F|||20230831143704-0400
NTE|1|RF|NEGATIVE  /HPF|RF^^^
